Adenosine deaminase |
Km |
= |
140000.0 |
nM |
Kinetic constant (Km) for the deamination of compound by adenosine deaminase |
CHEMBL1132757 |
Adenosine deaminase |
Vmax |
= |
95.0 |
uM min-1 (mg of protein)-1 |
Kinetic constant (Vmax) for the deamination of compound by adenosine deaminase |
CHEMBL1132757 |
Adenosine deaminase |
Relative Vmax |
= |
33.0 |
|
Kinetic constant (relative Vmax) for the deamination of compound by adenosine deaminase |
CHEMBL1132757 |
Adenosine deaminase |
Ratio |
= |
0.7 |
|
Ratio of kinetic constant (Vmax/Km) for the deamination of compound by adenosine deaminase |
CHEMBL1132757 |
Adenosine deaminase |
Km |
= |
110000.0 |
nM |
Kinetic constant (Km) for the deamination of compound by adenosine deaminase |
CHEMBL1132757 |
Adenosine deaminase |
Vmax |
= |
6.0 |
uM min-1 (mg of protein)-1 |
Kinetic constant (Vmax) for the deamination of compound by adenosine deaminase |
CHEMBL1132757 |
Adenosine deaminase |
Relative Vmax |
= |
2.0 |
|
Kinetic constant (relative Vmax) for the deamination of compound by adenosine deaminase |
CHEMBL1132757 |
Adenosine deaminase |
Ratio |
= |
0.05 |
|
Ratio of kinetic constant (Vmax/Km) for the deamination of compound by adenosine deaminase |
CHEMBL1132757 |
L1210 |
IC50 |
= |
690.0 |
nM |
In vitro tumor cell growth inhibitory activity against mouse leukemia L1210 cell lines. |
CHEMBL1129576 |
KB |
IC50 |
= |
830.0 |
nM |
In vitro tumor cell growth inhibitory activity against human nasopharyngeal KB cell lines |
CHEMBL1129576 |
Human herpesvirus 2 strain G |
Activity |
|
|
|
Antiviral activity against HSV-2 G at 100 uM |
CHEMBL3785043 |
Human herpesvirus 2 |
Activity |
|
|
|
Antiviral activity against HSV-2 lyons at 100 uM |
CHEMBL3785043 |
Human herpesvirus 1 strain KOS |
Activity |
|
|
|
Antiviral activity against Aciclovir-resistant thymidine kinase-deficient HSV-1 KOS at 100 uM |
CHEMBL3785043 |
Human herpesvirus 1 strain KOS |
Activity |
|
|
|
Antiviral activity against HSV-1 KOS at 100 uM |
CHEMBL3785043 |
Human herpesvirus 5 strain AD169 |
Activity |
|
|
|
Antiviral activity against Human cytomegalovirus AD169 at 100 uM |
CHEMBL3785043 |
Human herpesvirus 5 |
Activity |
|
|
|
Antiviral activity against Human cytomegalovirus Davis at 100 uM |
CHEMBL3785043 |
Vaccinia virus |
EC50 |
= |
350.0 |
nM |
Antiviral activity against Vaccinia virus Lederle |
CHEMBL3785043 |
Human adenovirus type 2 |
Activity |
|
|
|
Antiviral activity against Adenovirus 2 at 100 uM |
CHEMBL3785043 |
Respiratory syncytial virus |
Activity |
|
|
|
Antiviral activity against Respiratory syncytial virus long at 100 uM |
CHEMBL3785043 |
Vesicular stomatitis virus |
Activity |
|
|
|
Antiviral activity against VSV at 100 uM |
CHEMBL3785043 |
Human coxsackievirus B4 |
Activity |
|
|
|
Antiviral activity against Coxsackie B4 virus at 100 uM |
CHEMBL3785043 |
Human parainfluenza virus 3 |
Activity |
|
|
|
Antiviral activity against parainfluenza virus 3 at 100 uM |
CHEMBL3785043 |
Influenza A virus |
Activity |
|
|
|
Antiviral activity against Influenza virus A H1N1 at 100 uM |
CHEMBL3785043 |
Influenza A virus |
Activity |
|
|
|
Antiviral activity against Influenza virus A H3N2 at 100 uM |
CHEMBL3785043 |
Influenza B virus |
Activity |
|
|
|
Antiviral activity against Influenza virus B at 100 uM |
CHEMBL3785043 |
Sindbis virus |
Activity |
|
|
|
Antiviral activity against Sindbis virus at 100 uM |
CHEMBL3785043 |
NON-PROTEIN TARGET |
Activity |
|
|
|
Antiviral activity against Reovirus 1 at 100 uM |
CHEMBL3785043 |
Punta Toro virus |
Activity |
|
|
|
Antiviral activity against Punta Toro virus at 100 uM |
CHEMBL3785043 |
Human immunodeficiency virus 1 |
Activity |
|
|
|
Antiviral activity against HIV1 3B infected in human MT4 cells at 100 uM preincubated with cells for 30 mins followed by HIV inoculation measured after 4 to 5 days by microscopic analysis |
CHEMBL3785043 |
Human immunodeficiency virus 1 |
Activity |
|
|
|
Antiviral activity against HIV 1 NL4-3 infected in human MT4 cells at 100 uM preincubated with cells for 30 mins followed by HIV inoculation measured after 4 to 5 days by microscopic analysis |
CHEMBL3785043 |
Human immunodeficiency virus type 2 (ISOLATE ROD) |
Activity |
|
|
|
Antiviral activity against HIV2 ROD infected in human MT4 cells at 100 uM preincubated with cells for 30 mins followed by HIV inoculation measured after 4 to 5 days by microscopic analysis |
CHEMBL3785043 |
L1210 |
IC50 |
= |
730.0 |
nM |
Cytostatic activity against mouse L1210 cells after 48 hrs by Coulter counter method |
CHEMBL3785043 |
CEM |
IC50 |
= |
610.0 |
nM |
Cytostatic activity against human CEM cells after 72 hrs by Coulter counter method |
CHEMBL3785043 |
HeLa |
IC50 |
= |
290.0 |
nM |
Cytostatic activity against human HeLa cells after 72 hrs by Coulter counter method |
CHEMBL3785043 |
Human herpesvirus 5 |
EC50 |
>= |
4000.0 |
nM |
Antiviral activity against Human cytomegalovirus Davis strain infected in HELF cells assessed as inhibition of virus-induced cytopathogenicity |
CHEMBL4270599 |
Human herpesvirus 5 strain AD169 |
EC50 |
>= |
4000.0 |
nM |
Antiviral activity against Human cytomegalovirus AD169 strain infected in HELF cells assessed as inhibition of virus-induced cytopathogenicity |
CHEMBL4270599 |
Human herpesvirus 3 |
EC50 |
= |
1640.0 |
nM |
Antiviral activity against thymidine kinase-deficient Varicella Zoster virus 07-1 strain infected in HELF cells assessed as inhibition of virus-induced plaque formation |
CHEMBL4270599 |
Human herpesvirus 3 strain Oka vaccine |
EC50 |
= |
1820.0 |
nM |
Antiviral activity against thymidine kinase-deficient Varicella Zoster virus Oka strain infected in HELF cells assessed as inhibition of virus-induced plaque formation |
CHEMBL4270599 |
Unchecked |
CC50 |
= |
700.0 |
nM |
Cytotoxicity against HELF cells after by Coulter counter method |
CHEMBL4270599 |
Unchecked |
MCC |
= |
20000.0 |
nM |
Cytotoxicity against HELF cells assessed as alteration of cell morphology by microscopic analysis |
CHEMBL4270599 |
Vaccinia virus |
EC50 |
= |
350.0 |
nM |
Antiviral activity against Vaccinia virus Lederle infected in HELF cells assessed as inhibition of virus-induced cytopathogenicity |
CHEMBL4270599 |
Human herpesvirus 1 strain KOS |
EC50 |
> |
4000.0 |
nM |
Antiviral activity against thymidine kinase-deficient acyclovir-resistant Human herpesvirus 1 KOS strain infected in HELF cells assessed as inhibition of virus-induced cytopathogenicity |
CHEMBL4270599 |
Human herpesvirus 2 strain G |
EC50 |
> |
4000.0 |
nM |
Antiviral activity against Human herpesvirus 2 G strain infected in HELF cells assessed as inhibition of virus-induced cytopathogenicity |
CHEMBL4270599 |
Human herpesvirus 1 strain KOS |
EC50 |
> |
4000.0 |
nM |
Antiviral activity against Human herpesvirus 1 KOS strain infected in HELF cells assessed as inhibition of virus-induced cytopathogenicity |
CHEMBL4270599 |
HeLa |
IC50 |
= |
290.0 |
nM |
Antiproliferative activity against human HeLa cells after 72 hrs by Coulter counter method |
CHEMBL4270599 |
CCRF-CEM |
IC50 |
= |
610.0 |
nM |
Antiproliferative activity against human CEM cells after 72 hrs by Coulter counter method |
CHEMBL4270599 |
L1210 |
IC50 |
= |
730.0 |
nM |
Antiproliferative activity against mouse L1210 cells after 48 hrs by Coulter counter method |
CHEMBL4270599 |